Matt Abernethy, CFO: Neurocrine Biosciences NBIX Sell · Filed 23/08/23

Trade details

Type: Insider sale
Amount: $228,955.48
Shares · price: 2,132 sh · $107.39 a share
Held after: 27,131 sh
Stock: Neurocrine Biosciences NBIX
Person: Matt AbernethyCFO
Trade date: 23/08/21
Filed: 23/08/23
Days to filing: 2 days

Sold 7.3% of holdings

Share of holding sold: 7.3%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/07/22~23/09/20

Matt Abernethy's recent trades

Matt AbernethyOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$361K
2,311 sh
$361K
Filed 09/14
Traded 09/14
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$140.9K
1,206 sh
$140.9K
Filed 25/02/14
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$158.4K
1,352 sh
$158.4K
Filed 25/02/13
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$141.3K
1,206 sh
$141.3K
Filed 25/02/13
Traded 25/02/13